Under the given circumstances where FDA had not been that...

  1. 46 Posts.
    Under the given circumstances where FDA had not been that supportive with AXIRON and bad sentiments in the market, sales of $39.1m is not at all bad. Its still 100k more than the 2014 Q1. Share holder should be happy with results.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.9¢
Change
0.000(0.00%)
Mkt cap ! $7.747M
Open High Low Value Volume
1.9¢ 1.9¢ 1.9¢ $5.562K 292.7K

Buyers (Bids)

No. Vol. Price($)
4 381825 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 60000 2
View Market Depth
Last trade - 15.04pm 20/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.